| ISSN |
2150-5349 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Protective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Madhav Changela, Sagar Pandey, Janak Bahirwani, Nishit Patel, Maulik Kaneriya, Sanket D Basida, Anish Shah, Rahul Thakur, Krishna Bodrya, Suruchi Jai Kumar Ahuja and Yecheskel Schneider |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Madhav Changela, MD, Doctor, Doctor, Department of Internal Medicine, One Brooklyn Health System/Interfaith Medical Center, 1545 Atlantic Av, Brooklyn, NY 11213, United States. changelamadhav@gmail.com |
| Key Words |
Inflammatory bowel disease; Anticoagulation; Antiplatelet therapy; Healthcare utilization; Mortality |
| Core Tip |
In this retrospective study, hospitalized inflammatory bowel disease (IBD) patients on long-term antiplatelet or anticoagulant therapy demonstrated benefits in terms of inpatient mortality, length of stay, and total hospitalization charges compared to those not on such therapy. While the use of anticoagulation alone or in combination with antiplatelet agents was linked to higher odds of lower gastrointestinal bleeding, there was no significant difference in the development of acute kidney injury, sepsis, or the use of total parenteral nutrition. Further research is needed to optimize treatment strategies and inform clinical decision-making in the IBD population. |
| Publish Date |
2024-10-25 03:02 |
| Citation |
<p>Changela M, Pandey S, Bahirwani J, Patel N, Kaneriya M, Basida SD, Shah A, Thakur R, Bodrya K, Jai Kumar Ahuja S, Schneider Y. Protective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel disease. <i>World J Gastrointest Pharmacol Ther</i> 2024; 15(6): 95532</p> |
| URL |
https://www.wjgnet.com/2150-5349/full/v15/i6/95532.htm |
| DOI |
https://dx.doi.org/10.4292/wjgpt.v15.i6.95532 |
